The inaugural International Brain Health Conference 2026 in Edinburgh will [...]
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]
Lario Therapeutics awarded $2.4M by The Michael J. Fox Foundation [...]
Evinova has announced collaborations with Astellas Pharma, AstraZeneca and Bristol [...]
Affibody licensee Rallybio reports Phase 1 data showing sustained complement inhibition with RLYB116
Affibody has reported positive Phase 1 data from its licensee [...]
Sensei Biotherapeutics has acquired Faeth Therapeutics and announced a concurrent [...]
Polaryx Therapeutics, Inc has selected a leading contract research organization [...]
GSK announced that the European Commission has approved Exdensur (depemokimab) [...]
ViiV Healthcare will present new data from its long-acting and [...]
Compass Pathways reports positive second Phase 3 trial for COMP360 in treatment-resistant depression
Compass Pathways has reported that its second pivotal Phase 3 [...]